Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11991)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2015 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Neurology
ISSN
2218-6212
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wong E, Vishwanath VA, Kister I. Rituximab in neuromyelitis optica: A review of literature. World J Neurol 2015; 5(1): 39-46 [DOI: 10.5316/wjn.v5.i1.39] |
|---|---|
| URL: | https://www.wjgnet.com/2218-6212/full/v5/i1/39.htm |
| Number | Citing Articles |
| 1 |
Suparna Saha, Soumava Mukherjee, Gautam Guha, Debashis Mukhopadhyay. Proteomic profiles of major serum proteins in seropositive NMO patients alter after Rituximab treatment. Journal of Proteins and Proteomics 2020; 11(2): 93 doi: 10.1007/s42485-020-00036-9
|
| 2 |
Krystian Obara, Marta Waliszewska-Prosół, Sławomir Budrewicz, Paweł Szewczyk, Maria Ejma. Severe course of neuromyelitis optica in a female patient with chronic C hepatitis. Neurologia i Neurochirurgia Polska 2018; 52(3): 397 doi: 10.1016/j.pjnns.2018.01.004
|
| 3 |
Dominique Rosales, Ilya Kister. Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder. Current Allergy and Asthma Reports 2016; 16(6) doi: 10.1007/s11882-016-0619-4
|
| 4 |
Hao Wang, Juanping Zhou, Yi Li, Lili Wei, Xintong Xu, Jianping Zhang, Kehu Yang, Shihui Wei, Wenfang Zhang. Adverse events of rituximab in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Therapeutic Advances in Neurological Disorders 2021; 14 doi: 10.1177/17562864211056710
|
| 5 |
Asya Izraelit Wallach, Matthew Tremblay, Ilya Kister. Advances in the Treatment of Neuromyelitis Optica Spectrum Disorder. Neurologic Clinics 2021; 39(1): 35 doi: 10.1016/j.ncl.2020.09.003
|
| 6 |
Ilya Kister, Friedemann Paul. Pushing the boundaries of neuromyelitis optica. Neurology 2015; 85(2): 118 doi: 10.1212/WNL.0000000000001749
|
| 7 |
G. Romero, M. Ticchioni, M. Cohen, M.A. Rosenthal-Allieri, L. Mondot, C. Lebrun Frenay. Neuromyelitis optica: Contribution of therapeutic responses markers monitoring in patients given rituximab. Revue Neurologique 2016; 172(3): 220 doi: 10.1016/j.neurol.2015.12.004
|
| 8 |
Linjun Cai, Ziyan Shi, Hongxi Chen, Qin Du, Ying Zhang, Zhengyang Zhao, Jiancheng Wang, Yanling Lang, Lingyao Kong, Hongyu Zhou. Relationship between the Clinical Characteristics in Patients with Neuromyelitis Optica Spectrum Disorders and Clinical Immune Indicators: A Retrospective Study. Brain Sciences 2022; 12(3): 372 doi: 10.3390/brainsci12030372
|
| 9 |
Edgar Patricio Correa-Díaz, Germaine Eleanor Torres-Herrán, Joselyn Elizabeth Miño Zambrano, Víctor Paredes-Gonzalez, Francisco José Caiza-Zambrano. Impact of Rituximab on relapse rate and disability in an Ecuadorian cohort of patients with neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders 2021; 48: 102683 doi: 10.1016/j.msard.2020.102683
|